Aimee Hagerty’s Post

I would like to discuss the issues on the November 26 Nikkei Shimbun article, "MBOs to Top 1 Trillion Yen in 2023, Taisho Pharmaceutical and Benesse Following in Succession."

SPAC Feed: Swiftmerge Acquisition in an 8-K said it terminated a merger agreement with HDL Therapeutucs. The decision was mutual and no… - https://lnkd.in/edYKSuTV #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic #finance #business

https://lnkd.in/eViWjw-9 another deal announced as we end the historically low Deals market in 2023 ... should be a great sign once again for a highly anticipated 2024, Bankers and M&A folks are almost expecting a great year in Deals, #investmentbanking #lifesciences #mergersacquisitionsdivestitures #deals

Thoughts on this? >> Flagship appears to boost target of 8th fund by up to $500M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharma #pharmaceutical #biotech

28 Ventures portfolio company update: "Viewing insider transactions for CytoMed Therapeutics Limited  (NASDAQ:GDTC ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold… One CytoMed Therapeutics Insider Raised Stake By 46%" https://bit.ly/40z8p1s #investing #privateequity #privatecapital #gopublic #venturecapital #IPOannouncement #publicventure #publicventurecapital #limitedpartnership #limitedpartnerships #boutiqueventure #VC #boutiquevc #preIPOinvesting #preIPO #LPs #flewber #flewberglobal #valueinvesting

Thoughts on this? >> Flagship appears to boost target of 8th fund by up to $500M >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #pharmaceutical #productmarketing #healthcare

Check this portfolio in April 2024: Cardinal Health( $CAH ), Hashicorp( $HCP ), General Dynamics( $GD ), Omega Therapeutics( $OMGA ), Chevron Corp( $CVX ), Prologis( $PLD ), Principal Financial( $PFG ), Gannett( $GCI ) and Equifax( $EFX ) https://lnkd.in/gBTVcvNC #stocks #stocktwits #thematic_portfolio

Thoughts on this? >> Avantor sells off CRO for $650M to private equity firm >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #productmarketing #pharma #pharmaceutical

Thoughts on this? >> Avantor sells off CRO for $650M to private equity firm >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical

The Venture Letter™ - Update Report on XORTX Therapeutics Inc. (NASDAQ: XRTX / TSXV: XRTX / Frankfurt: ANUA) - We are pleased to provide interested investors with an update report on XORTX Therapeutics Inc. Since the beginning of 2024, there have been numerous multi-billion dollar, biotech buyouts that must be considered when considering becoming a shareholder in XORTX. Good luck and good hunting. #XORTX #TheVentureLetter #XRTX #Biotechs #Buyouts #NASDAQ #TSXV #Biotechstocks #kidneydisease #stocks